{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:33:21Z","timestamp":1771457601000,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T00:00:00Z","timestamp":1302825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00520-011-1147-3","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T00:13:58Z","timestamp":1302740038000},"page":"767-772","source":"Crossref","is-referenced-by-count":12,"title":["Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?"],"prefix":"10.1007","volume":"20","author":[{"given":"Janet","family":"Hardy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,15]]},"reference":[{"key":"1147_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/bmc.1103","volume":"23","author":"R Mullangi","year":"2009","unstructured":"Mullangi R, Agrawal S, Srinivas N (2009) Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives. Biomed Chromatogr 23:3\u201325","journal-title":"Biomed Chromatogr"},{"key":"1147_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jchromb.2008.02.009","volume":"865","author":"C Michael","year":"2008","unstructured":"Michael C, Teichert J, Preiss R (2008) Determination of voriconazole in human plasma and saliva using high performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 865:74\u201380","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1147_CR3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0269881106060585","volume":"20","author":"P Gallagher","year":"2006","unstructured":"Gallagher P, Leitch M, Massey A, McAllister-Williams R, Young A (2006) Assessing cortisol and dehydroepiandrosterone (DHEA) in saliva: effect of collection method. J Psychopharmacol 20:643\u2013649","journal-title":"J Psychopharmacol"},{"key":"1147_CR4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00280-005-0166-5","volume":"58","author":"S Poujol","year":"2006","unstructured":"Poujol S, Bressolle F, Duffour J, Abderrahim AG, Astre C, Ychou M, Pinguet F (2006) Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen. Cancer Chemother Pharmacol 58:292\u2013305","journal-title":"Cancer Chemother Pharmacol"},{"key":"1147_CR5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/074873049701200507","volume":"12","author":"A Voultsios","year":"1997","unstructured":"Voultsios A, Kennaway D, Dawson D (1997) Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. J Biol Rhythms 12:457\u2013466","journal-title":"J Biol Rhythms"},{"key":"1147_CR6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/bdd.728","volume":"31","author":"ME Ruiz","year":"2010","unstructured":"Ruiz ME, Conforti P, Fagiolino P, Volont\u00e9 MG (2010) The use of saliva as a biological fluid in relative bioavailability studies: comparison and correlation with plasma results. Biopharm Drug Dispos 31:476\u2013485","journal-title":"Biopharm Drug Dispos"},{"key":"1147_CR7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1211\/002235703765344540","volume":"55","author":"W Gubala","year":"2003","unstructured":"Gubala W, Zuba D (2003) Gender differences in the pharmacokinetics of ethanol in saliva and blood after oral ingestion. Pol J Pharmacol 55:639\u2013644","journal-title":"Pol J Pharmacol"},{"key":"1147_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000457481","volume":"9","author":"R Gorodischer","year":"1992","unstructured":"Gorodischer R, Koren G (1992) Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Dev Pharmacol Ther 9:161\u2013177","journal-title":"Dev Pharmacol Ther"},{"issue":"6","key":"1147_CR9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00007691-199712000-00006","volume":"19","author":"R Gorodischer","year":"1997","unstructured":"Gorodischer R, Burtin P et al (1997) Is saliva suitable for therapeutic monitoring of anticonvulsants in children: an evaluation in the routine clinical setting. Ther Drug Monit 19(6):637\u2013642","journal-title":"Ther Drug Monit"},{"key":"1147_CR10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1177\/0091270003257229","volume":"43","author":"P Gandia","year":"2003","unstructured":"Gandia P, Bareille M, Saivin S, Pavy Le-Traon A, Lavit M, Guell A, Houin G (2003) Influence of simulated weightlessness on the oral pharmacokinetics of acetaminophen as a gastric emptying probe in man: a plasma and a saliva study. J Clin Pharmacol 43:1235\u20131243","journal-title":"J Clin Pharmacol"},{"key":"1147_CR11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/j.1552-4604.1987.tb03082.x","volume":"27","author":"WA Ritschel","year":"1987","unstructured":"Ritschel WA, Parab PV, Denson DD, Coyle DE, Gregg RV (1987) Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva\/plasma ratio and clinical effects. J Clin Pharmacol 27:647\u2013653","journal-title":"J Clin Pharmacol"},{"key":"1147_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00520-002-0385-9","volume":"11","author":"M Davis","year":"2003","unstructured":"Davis M, Varga J, Dickerson D, Walsh D, LeGrand SB, Lagman R (2003) Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. Support Care Cancer 11:84\u201392","journal-title":"Support Care Cancer"},{"key":"1147_CR13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2125.2010.03653.x","volume":"70","author":"J Gr\u00f6nlund","year":"2010","unstructured":"Gr\u00f6nlund J, Saari TI, Hagelberg NM, Neuvonen PJ, Olkkola KT, Laine K (2010) Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone. Br J Clin Pharmacol 70:78\u201387","journal-title":"Br J Clin Pharmacol"},{"key":"1147_CR14","volume-title":"Opioids in cancer pain","author":"P Glare","year":"2009","unstructured":"Glare P, Davis M (2009) Oxycodone. In: Davis M, Glare P, Hardy JR (eds) Opioids in cancer pain, 2nd edn. Oxford University Press, Oxford, UK","edition":"2"},{"key":"1147_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","volume":"79","author":"B Lalovic","year":"2006","unstructured":"Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen D (2006) Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin Pharmacol Ther 79:461\u2013479","journal-title":"Clin Pharmacol Ther"},{"key":"1147_CR16","doi-asserted-by":"crossref","unstructured":"Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundstr\u00f6m S, Kaasa S, Dale O (2011) Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients. Eur J Clin Pharmacol. doi: 10.1007\/s00228-010-0948-5","DOI":"10.1007\/s00228-010-0948-5"},{"key":"1147_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0952-8180(95)00092-5","volume":"8","author":"M Kirvela","year":"1996","unstructured":"Kirvela M, Lindgren L, Seppala T, Olkkola K (1996) The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation. J Clin Anesth 8:13\u201318","journal-title":"J Clin Anesth"},{"key":"1147_CR18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0009-9236(97)90100-4","volume":"61","author":"M Tallgren","year":"1997","unstructured":"Tallgren M, Olkkola KT, Seppala T, Hockerstedt K, Lindgren L (1997) Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation. Clin Pharmacol Ther 61:655\u2013661","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1147_CR19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/J354v18n04_03","volume":"18","author":"RA Lugo","year":"2004","unstructured":"Lugo RA, Kern SE (2004) The pharmacokinetics of oxycodone. J Pain Palliat Care Pharmacother 18(4):17\u201328","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"1147_CR20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jchromb.2006.10.039","volume":"848","author":"SR Edwards","year":"2007","unstructured":"Edwards SR, Smith MT (2007) Low levels of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. J Chromatogr 848:264\u2013270","journal-title":"J Chromatogr"},{"key":"1147_CR21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1191\/0269216303pm658oa","volume":"17","author":"C Quigley","year":"2003","unstructured":"Quigley C, Joel S, Patel N, Baksh A, Slevin M (2003) Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side-effects in patients with cancer-related pain. Palliat Med 17:185\u2013190","journal-title":"Palliat Med"},{"key":"1147_CR22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jat\/31.8.424","volume":"31","author":"E Cone","year":"2007","unstructured":"Cone E, Clarke J, Tsanaclis L (2007) Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. J Anal Toxicol 31:424\u2013433","journal-title":"J Anal Toxicol"},{"key":"1147_CR23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/23.6.452","volume":"23","author":"C O'Neal","year":"1999","unstructured":"O'Neal C, Crouch D, Rollins D, Fatah AA (1999) Correlation of saliva codeine concentrations with plasma concentrations after oral codeine administration. J Anal Toxicol 23:452\u2013459","journal-title":"J Anal Toxicol"},{"key":"1147_CR24","first-page":"108","volume":"20","author":"C Pourzitaki","year":"2006","unstructured":"Pourzitaki C, Tachou H et al (2006) Heroin metabolites detection in saliva and blood. Rev Clin Pharmacol Pharmacokinet 20:108\u2013109","journal-title":"Rev Clin Pharmacol Pharmacokinet"},{"key":"1147_CR25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.ftd.0000164392.01779.db","volume":"27","author":"M Shiran","year":"2005","unstructured":"Shiran M, Hassanzadeh-Khayyat M, Iqbal MZ et al (2005) Can saliva replace plasma for the monitoring of methadone? Ther Drug Monit 27:580\u2013586","journal-title":"Ther Drug Monit"},{"key":"1147_CR26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00007691-199710000-00008","volume":"19","author":"E Kopecky","year":"1997","unstructured":"Kopecky E, Jacobsen S, Klein J, Bhushan K, Gideon K (1997) Correlation of morphine sulphate in blood plasma and saliva in pediatric patients. Ther Drug Monit 19:530\u2013534","journal-title":"Ther Drug Monit"},{"key":"1147_CR27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/PL00007717","volume":"114","author":"G Skopp","year":"2001","unstructured":"Skopp G, P\u00f6tsch L, Klinder K, Richter B, Aderjan R, Mattern R (2001) Saliva testing after single and chronic administration of dihydrocodeine. Int J Leg Med 114:133\u2013140","journal-title":"Int J Leg Med"},{"issue":"10","key":"1147_CR28","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","volume":"36","author":"T Okura","year":"2008","unstructured":"Okura T, Hattori A, Takano Y, Sato T et al (2008) Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone. Drug Metab Dispos 36(10):2005\u20132013","journal-title":"Drug Metab Dispos"},{"key":"1147_CR29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(24)38199-6","volume":"289","author":"H Yabuuchi","year":"1999","unstructured":"Yabuuchi H, Tamai I, Nezu J, Sakamoto K et al (1999) Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cation. J Pharmacol Exp Ther 289:768\u2013773","journal-title":"J Pharmacol Exp Ther"},{"key":"1147_CR30","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1124\/dmd.110.034611","volume":"38","author":"MB Genter","year":"2010","unstructured":"Genter MB, Krishan M, Augustine LM, Cherrington NJ (2010) Drug transporter expression and localization in rat nasal respiratory and olfactory mucosa and olfactory bulb. Drug Metab Dispos 38:1644\u20131647","journal-title":"Drug Metab Dispos"},{"key":"1147_CR31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/00000542-200005000-00030","volume":"92","author":"SJ Thompson","year":"2000","unstructured":"Thompson SJ, Koszdin K, Bernards CM (2000) Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology 92:1392\u20131399","journal-title":"Anesthesiology"},{"key":"1147_CR32","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jps.20327","volume":"94","author":"E Bostr\u00f6m","year":"2005","unstructured":"Bostr\u00f6m E, Simonssen USH, Hammarlund-Udenaes M (2005) Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833. J Pharm Sci 94:1060\u20131066","journal-title":"J Pharm Sci"},{"key":"1147_CR33","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/jps.20893","volume":"96","author":"HE Hassan","year":"2007","unstructured":"Hassan HE, Myers AL, Lee IJ, Coop A et al (2007) Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats. J Pharm Sci 96:2494\u20132506","journal-title":"J Pharm Sci"},{"key":"1147_CR34","unstructured":"Mercer SL, Coop A (2011). Opioid analgesics and P-glycoprotein efflux tranporters: a potential systems-level contribution to analgesic tolerance. Curr Top Med Chem (in press)"},{"issue":"6","key":"1147_CR35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0003-9969(01)00012-7","volume":"46","author":"T Uematsu","year":"2001","unstructured":"Uematsu T, Yamaoka M, Matsuura T, Doto R et al (2001) P-glycoprotein expression in human major and minor salivary glands. Arch Oral Biol 46(6):521\u2013527","journal-title":"Arch Oral Biol"},{"issue":"7","key":"1147_CR36","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s11095-005-5420-3","volume":"22","author":"KK Kandimalla","year":"2005","unstructured":"Kandimalla KK, Donovan MD (2005) Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosa. Pharm Res 22(7):1121\u20131128","journal-title":"Pharm Res"},{"key":"1147_CR37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0169-409X(93)90039-7","volume":"12","author":"H Yamahara","year":"1993","unstructured":"Yamahara H, Lee VHL (1993) Drug metabolism in the oral cavity. Adv Drug Deliv Rev 12:25\u201340","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"1147_CR38","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1373\/clinchem.2008.108670","volume":"55","author":"W Bosker","year":"2009","unstructured":"Bosker W, Huestis M (2009) Oral fluid testing for drugs of abuse. Clin Chem 55(11):1910\u20131931","journal-title":"Clin Chem"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-011-1147-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-011-1147-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-011-1147-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T01:57:57Z","timestamp":1741139877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-011-1147-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,15]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1007\/s00520-011-1147-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,15]]}}}